Boothbay Fund Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $810K | Buy |
99,457
+50,000
| +101% | +$407K | 0.02% | 592 |
|
|
2025
Q1 | $388K | Sell |
49,457
-65,088
| -57% | -$511K | 0.01% | 803 |
|
|
2024
Q4 | $1.71M | Sell |
114,545
-112,026
| -49% | -$1.67M | 0.04% | 405 |
|
|
2024
Q3 | $3.46M | Buy |
226,571
+182,042
| +409% | +$2.78M | 0.08% | 281 |
|
|
2024
Q2 | $678K | Buy |
+44,529
| New | +$678K | 0.02% | 767 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 1672 |
|
|
2023
Q4 | – | Sell |
-55,772
| Closed | -$1M | – | 1738 |
|
|
2023
Q3 | $1M | Sell |
55,772
-138,408
| -71% | -$2.48M | 0.02% | 630 |
|
|
2023
Q2 | $3.94M | Sell |
194,180
-24,201
| -11% | -$492K | 0.09% | 240 |
|
|
2023
Q1 | $3.98M | Buy |
218,381
+190,537
| +684% | +$3.48M | 0.08% | 282 |
|
|
2022
Q4 | $576K | Buy |
+27,844
| New | +$576K | 0.01% | 923 |
|
|
2022
Q2 | – | Sell |
-30,800
| Closed | -$972K | – | 2252 |
|
|
2022
Q1 | $972K | Buy |
+30,800
| New | +$972K | 0.02% | 740 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 1948 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 1897 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 1878 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1524 |
|